Is EARS or MCD a better dividend investment in 2026?

EARS currently yields 65.68% with a 5% 5-year dividend growth rate. MCD yields 2.35% with 8.5% growth. The better choice depends on your goal: EARS offers higher current income.

What is the dividend yield difference between EARS and MCD?

EARS has a forward dividend yield of 65.68% ($2.00/share annually). MCD yields 2.35% ($7.26/share annually). The yield gap is 63.33 percentage points.

Home › Compare › EARS vs MCD

EARS vs MCD: Dividend Comparison 2026

EARS yields 65.68% · MCD yields 2.35%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EARS wins by $778.9K in total portfolio value

INVESTMENT

TIME HORIZON10 years

EARS

● Live price

65.68%

Share price

$3.05

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$857.5K

Annual income

$214,640.91

Full EARS calculator →

MCD

McDonald's Corporation

● Live price

2.35%

Share price

$308.53

Annual div

$7.26

5Y div CAGR

42.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$78.5K

Annual income

$26,227.70

Full MCD calculator →

Portfolio growth — EARS vs MCD

📍 EARS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EARS	MCD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EARS + MCD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EARS pays

MCD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EARS

Annual income on $10K today (after 15% tax)

$5,582.92/yr

After 10yr DRIP, annual income (after tax)

$182,444.77/yr

MCD

Annual income on $10K today (after 15% tax)

$200.01/yr

After 10yr DRIP, annual income (after tax)

$22,293.55/yr

At 15% tax rate, EARS beats the other by $160,151.23/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EARS + MCD for your $10,000?

EARS: 50%MCD: 50%

100% MCD50/50100% EARS

Portfolio after 10yr

$468.0K

Annual income

$120,434.30/yr

Blended yield

25.73%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

EARS

No analyst data

MCD

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$351.76

+14.0% upside vs current

Range: $320.00 — $385.00

Altman Z

4.9

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EARS buys

MCD buys

No recent congressional trades found for EARS or MCD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEARSMCD

Forward yield	65.68% ✓	2.35%
Annual dividend / share	$2.00	$7.26 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	42.3% ✓
Portfolio after 10y	$857.5K ✓	$78.5K
Annual income after 10y	$214,640.91 ✓	$26,227.70
Total dividends collected	$722.8K ✓	$58.5K
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Discretionary

Year-by-year: EARS vs MCD ($10,000, DRIP)

Year	EARS Portfolio	EARS Income/yr	MCD Portfolio	MCD Income/yr	Gap
1← crossover	$17,268	$6,568.14	$10,815	$334.85	+$6.5K → EARS
2	$29,077	$10,599.97	$11,826	$491.71	+$17.3K → EARS
3	$47,793	$16,681.04	$13,123	$730.06	+$34.7K → EARS
4	$76,764	$25,624.68	$14,853	$1,100.07	+$61.9K → EARS
5	$120,602	$38,464.70	$17,257	$1,690.61	+$103.3K → EARS
6	$185,521	$56,477.71	$20,752	$2,667.01	+$164.8K → EARS
7	$279,704	$81,195.93	$26,103	$4,354.83	+$253.6K → EARS
8	$413,691	$114,407.58	$34,794	$7,437.78	+$378.9K → EARS
9	$600,792	$158,142.40	$49,926	$13,461.60	+$550.9K → EARS
10	$857,488	$214,640.91	$78,550	$26,227.70	+$778.9K → EARS

EARS vs MCD: Complete Analysis 2026

EARS — Stock

Auris Medical Holding Ltd. engages in the development of novel products that address unmet medical needs in neurotology and central nervous system disorders. The company is headquartered in Zug, Zug and currently employs 11 full-time employees. The firm focuses on the development of intranasal betahistine for the treatment of vertigo (AM-125) and for the treatment of antipsychotic-induced weight gain and somnolence (AM-201). The betahistine program is in Phase 1 of clinical trials. Other programs in the Company's product pipeline include brimapitide-based AM-111 for the treatment of acute inner ear hearing loss and eskatemine-based Keyzilen (AM-101) for the treatment of acute inner ear tinnitus, both in Phase 3 of clinical trials, as well as AM-102 indicated for tinnitus, undergoing preclinical studies focused on selecting the lead compound. The firm operates through subsidiaries in Switzerland, Ireland and the United States.

Full EARS Calculator →

MCD — Consumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →

📬

Get this EARS vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EARS vs SCHD EARS vs JEPI EARS vs O EARS vs KO EARS vs MAIN EARS vs YUM EARS vs QSR EARS vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.